Skip to main navigation Skip to search Skip to main content

An open label phase 3 study to evaluate the safety and immunogenicity of the mRNA-1273.214 vaccine for SARS-CoV-2 variants of concern in participantes aged 6 months to < 6 years

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date04/2/23 → 04/1/25

Funding

  • ModernaTX: $25,450.00